| | | | | | | | | | |
| |
|
|
| Dockets Entered On November 29, 2006
|
|
|
|
|
|
|
| |
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
| |
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
| |
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
| |
|
|
| 2003P-0544
|
| Modify existing food additive regulation with respect to the irradiation of ground beef byproducts
|
| |
|
|
| 2005D-0310
|
| Guidance for Industry on Gene Therapy Clinical Trials Observing Participants for Delayed Adverse Events
|
| |
|
|
| 2005N-0097
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
| |
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
| |
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
| |
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
| |
|
|
| 2006D-0336
|
| Guidance for Industry and Food and Drug Administration Staff; Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions
|
| |
|
|
| 2006D-0344
|
| Guidance for Industry on Drug Interaction Studies--Study Design, Data Analysis, and Implications for Dosing and Labeling
|
| |
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
| |
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
| |
|
|
| 2006E-0478
|
| Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913
|
| |
|
|
| 2006N-0335
|
| Medical Devices; Reprocessed Single-Use Devices; Requirement for Submission of
|
| |
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
| |
|
|
| 2006N-0414
|
| Suicidality Data from Adult Antidepressant Trials
|
| |
|
|
| 2006N-0452
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Agreement for Shipment of Devices for Sterilization
|
| |
|
|
| 2006N-0465
|
| Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products; Public Meeting
|
| |
|
|
| 2006N-0468
|
| Training Program for Regulatory Project Managers; Information Available to Industry
|
| |
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
| |
|
|
| 2006P-0481
|
| ANDA Suitability for Oxycodone Hydrochloride Capsules, 5 mg
|
| |
|
|
| 2006P-0484
|
| Change the indication for Stimulant Medications for the Treatment of Mental Diseases
|
| |
|
|
| 2006V-0482
|
| Laser Light Show
|
| |
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
| |
|
|
| C 42
|
| Gundersen Lutheran Clinic, Ltd
|
| Vol #:
|
| 15
|
| |
|
|
| EC 99
|
| Mayo Clinic
|
| Vol #:
|
| 14
|
| |
|
|
| EC 100
|
| Dr. Kris Howard
|
| Vol #:
|
| 14
|
| |
|
|
| EC 101
|
| Dr. Dorota Wilson
|
| Vol #:
|
| 14
|
| |
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
| |
|
|
| EMC 742
|
| Calorie Control Council
|
| Vol #:
|
| 10
|
| |
|
|
| EMC 743
|
| Calorie Control Council
|
| Vol #:
|
| 10
|
| |
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
| |
|
|
| EMC 1388
|
| K. White
|
| Vol #:
|
| 12
|
|
| | | | | | | | |
| |
|
|
| 2003P-0544
|
| Modify existing food additive regulation with respect to the irradiation of ground beef byproducts
|
| |
|
|
| C 70
|
| L. Husted
|
| Vol #:
|
| 5
|
| |
|
|
| 2005D-0310
|
| Guidance for Industry on Gene Therapy Clinical Trials Observing Participants for Delayed Adverse Events
|
| |
|
|
| GDL 2
|
| Guidance
|
| Vol #:
|
| 1
|
| |
|
|
| NAD 2
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2005N-0097
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
| |
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
| |
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
|
|
|
|
|
|
|
|
| EMC 4
Attachment |
| National Institute of Standards & Technology
| China
|
| Vol #:
|
| 4
|
| |
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
| |
|
|
| EMC 4154
|
| C. Marsh
|
| Vol #:
|
| 195
|
| |
|
|
| EMC 4155
|
| L. Paolilli
|
| Vol #:
|
| 195
|
| |
|
|
| EMC 4156
|
| L. Apatini
|
| Vol #:
|
| 195
|
| |
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
| |
|
|
| C 12
|
| American Brain Injury Consortium
|
| Vol #:
|
| 3
|
| |
|
|
| EMC 5
|
| N. I. H.-Office of Biotechnology Activities-Office of Science Policy-Office of the Director
|
| Vol #:
|
| 3
|
| |
|
|
| 2006D-0336
|
| Guidance for Industry and Food and Drug Administration Staff; Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions
|
| |
|
|
| NEC 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006D-0344
|
| Guidance for Industry on Drug Interaction Studies--Study Design, Data Analysis, and Implications for Dosing and Labeling
|
| |
|
|
| C 10
|
| Boehringer-Ingelheim Pharmaceuticals
|
| Vol #:
|
| 1
|
| |
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
| |
|
|
| NEC 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
|
|
|
|
| C 136
|
| B. McDonnell
|
| Vol #:
|
| 9
|
| |
|
|
| C 137
|
| J and H Costello
|
| Vol #:
|
| 9
|
| |
|
|
| C 138
|
| J. Gaes
|
| Vol #:
|
| 9
|
| |
|
|
| C 139
|
| D. Parry MA, CChem, MRSC, dip lib, MCLIP
|
| Vol #:
|
| 9
|
| |
|
|
| C 140
|
| C. Angelo
|
| Vol #:
|
| 9
|
| |
|
|
| C 141
|
| M. Sickels
|
| Vol #:
|
| 9
|
|
| | | | | | | |
| |
|
|
| C 142
|
| M. Webster
|
| Vol #:
|
| 9
|
| |
|
|
| C 143
|
| T. Capano
|
| Vol #:
|
| 9
|
| |
|
|
| C 144
|
| A. Springer
|
| Vol #:
|
| 9
|
| |
|
|
| C 145
|
| S. Stewart
|
| Vol #:
|
| 9
|
| |
|
|
| C 146
|
| D. Jabaley
|
| Vol #:
|
| 9
|
| |
|
|
| C 147
|
| W. and C Yontz
|
| Vol #:
|
| 9
|
| |
|
|
| C 148
|
| E. Mohler
|
| Vol #:
|
| 9
|
| |
|
|
| C 149
|
| L. Sosa
|
| Vol #:
|
| 9
|
| |
|
|
| C 150
|
| D. Laurens, M.A.
|
| Vol #:
|
| 9
|
| |
|
|
| C 151
|
| K. Kremer
|
| Vol #:
|
| 9
|
| |
|
|
| C 152
|
| M and T Ruppert
|
| Vol #:
|
| 9
|
| |
|
|
| C 153
|
| W. Murphy
|
| Vol #:
|
| 9
|
| |
|
|
| C 154
|
| C. Flugel
|
| Vol #:
|
| 9
|
| |
|
|
| C 155
|
| M. Brazwell
|
| Vol #:
|
| 9
|
| |
|
|
| C 156
|
| J. Muller
|
| Vol #:
|
| 9
|
| |
|
|
| C 157
|
| A. Popiel
|
| Vol #:
|
| 9
|
| |
|
|
| C 158
|
| P. Pokorny
|
| Vol #:
|
| 9
|
| |
|
|
| EC 2254
|
| Mr. Robert Stein
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2255
|
| Mr. Brian/Shawna Harrington
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2256
|
| Mrs. Christine Case
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2257
|
| Dr. MaryTim Baggott
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2258
|
| Mr. Thomas Lindley
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2259
|
| Mr. Eric Fedewa
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2260
|
| Mrs. Alice Shelton
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2261
|
| Life Matters
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2262
|
| Mrs. Della Schoenecker
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2263
|
| Mrs. Angela Anderson
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2264
|
| Comsumer Group (Catholic)
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2265
|
| Mrs. Suzanne Kobzdej
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2266
|
| Mrs. Joan Hephner
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2267
|
| Ms. Judith Hankel, Caregiver
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2268
|
| Mrs. Monica Mountain
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2269
|
| Mrs. Michelle Lynch
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2270
|
| Mrs. Carol Lyvers
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2271
|
| Mr. Charles Mosco
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2272
|
| Mrs. Elizabeth Ortega
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2273
|
| Mrs. Laura Quesenberry
|
| Vol #:
|
| 8
|
|
| | | | | | | |
| |
|
|
| EC 2274
|
| Mr. Steven Henstebeck
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2275
|
| Mrs. Cheryl Waguespack
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2276
|
| Mr. Dan Brown
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2277
|
| Mrs. Betsy Kerekes
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2278
|
| Mrs. Elizabeth Larson
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2279
|
| Ms. Jennifer Lawler
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2280
|
| Mr. Don Demas
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2281
|
| Dr. Michele Hedspeth
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2282
|
| Mrs. Jennifer Reesman
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2283
|
| Mrs. Laurel Gorney
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2284
|
| Mrs. colleen milz
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2285
|
| Mrs. Nancy Payton
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2286
|
| Miss. Susan Gustavson
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2287
|
| Dr. AiXuan Holterman
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2288
|
| Mrs. Lavona Rann
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2289
|
| Ms. Rhonda L Mannino
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2290
|
| Mrs. Brenda Beverly
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2291
|
| Ms. Donna Kisel, RN-CAPA
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2292
|
| Mrs. Christina Durnil
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2293
|
| Mr. Thomas Chelak
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2294
|
| Mr. Tim Heeren
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2295
|
| Mrs. Carol Alvarado
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2296
|
| Mr. David Trask
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2297
|
| Mr. Joseph Santucci
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2298
|
| Mr. JOHN ALVARADO
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2299
|
| Mrs. Elizabeth Skrzynecka-Carlos
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2300
|
| none
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2301
|
| Mrs. Teresa Geoffroy
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2302
|
| Mr. David Mack
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2303
|
| Mr. Steve Hamilton
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2304
|
| Mr. Pablo Dominguez
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2305
|
| Mr. Joseph Crnkovich
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2306
|
| Mr. Robert Colon
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2307
|
| Mr. james l. barnes
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2308
|
| Ms. joyce brady
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2309
|
| Mrs. Brenda Kolic
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2310
|
| Mrs. Bridget Helm
|
| Vol #:
|
| 8
|
|
| | | | | | | | |
| |
|
|
| EC 2311
|
| Mrs. Penny Mallo
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2312
|
| Dr. Elizabeth Berger
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2313
|
| Mr. Tom Nathe
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2314
|
| Ms. Mary Moroney
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2315
|
| Mrs. Geraldine Korman
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2316
|
| Mr. Gregory Tashjian
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2317
|
| Mr. Don Ross
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2318
|
| Mr. CHARLES DEREUIL
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2319
|
| Mr. Ralph Colucci
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2320
|
| Mr. Mark Lysecky
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2321
|
| Mrs. Wanda Formentini
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2322
|
| Mr. Philip Hesselbein
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2323
|
| Mrs. Elizabeth Logan
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2324
|
| Mrs. Jennifer Schuler
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2325
|
| Mrs. Patricia Katagiri
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2326
|
| Citizens for a Pro-Life Society-WI
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2327
|
| Mrs. Kara Coleman
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2328
|
| Mrs. suzanne brixius
|
| Vol #:
|
| 8
|
| |
|
|
| EC 2329
|
| Mr. Chris Donatto
|
| Vol #:
|
| 8
|
| |
|
|
| 2006E-0478
|
| Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913
|
| |
|
|
| APP 1
|
| Novo Nordisk Inc.
|
| Vol #:
|
| 1
|
| |
|
|
| LET 1
|
| U.S. Patent and Trademark Office to FDA/CDER
|
| Vol #:
|
| 1
|
| |
|
|
| LET 2
|
| U.S. Patent and Trademark Office to Novo Nordisk Inc.
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0335
|
| Medical Devices; Reprocessed Single-Use Devices; Requirement for Submission of
|
| |
|
|
| EC 1
|
| Mr. michael nichols
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
| |
|
|
| C 562
|
| V. Walton
|
| Vol #:
|
| 27
|
| |
|
|
| C 563
|
| J. Mines
|
| Vol #:
|
| 27
|
| |
|
|
| C 564
|
| R. Wilson
|
| Vol #:
|
| 27
|
| |
|
|
| C 565
|
| J. Schaefer
|
| Vol #:
|
| 27
|
| |
|
|
| C 566
|
| D. NAdeau
|
| Vol #:
|
| 27
|
| |
|
|
| C 567
|
| L. Porter
|
| Vol #:
|
| 27
|
| |
|
|
| C 568
|
| L and J Warren
|
| Vol #:
|
| 27
|
| |
|
|
| C 569
|
| T. Paolucci
|
| Vol #:
|
| 27
|
| |
|
|
| C 570
|
| B. Silverman
|
| Vol #:
|
| 27
|
|
| | | | | | | |
| |
|
|
| C 571
|
| C. Neurath
|
| Vol #:
|
| 27
|
| |
|
|
| C 572
|
| V. Barber
|
| Vol #:
|
| 27
|
| |
|
|
| C 573
|
| M. Yates
|
| Vol #:
|
| 27
|
| |
|
|
| C 574
|
| K. Douglas
|
| Vol #:
|
| 27
|
| |
|
|
| C 575
|
| J. Stromseth
|
| Vol #:
|
| 27
|
| |
|
|
| C 576
|
| L. Fettig
|
| Vol #:
|
| 27
|
| |
|
|
| C 577
|
| K. Yagemann
|
| Vol #:
|
| 27
|
| |
|
|
| C 578
|
| J. Short, DDS, MSc, DIHom
|
| Vol #:
|
| 27
|
| |
|
|
| C 579
|
| J. Ebbott
|
| Vol #:
|
| 27
|
| |
|
|
| C 580
|
| T. White
|
| Vol #:
|
| 27
|
| |
|
|
| C 581
|
| H and V Distad
|
| Vol #:
|
| 27
|
| |
|
|
| C 582
|
| D. Johnson
|
| Vol #:
|
| 27
|
| |
|
|
| C 583
|
| C. Verge
|
| Vol #:
|
| 27
|
| |
|
|
| C 584
|
| Arizona Homeopathic and Integrative Medical Association
|
| Vol #:
|
| 27
|
| |
|
|
| C 585
|
| C. Spencer
|
| Vol #:
|
| 27
|
| |
|
|
| C 586
|
| A. North
|
| Vol #:
|
| 27
|
| |
|
|
| C 587
|
| L. Henderson
|
| Vol #:
|
| 27
|
| |
|
|
| C 588
|
| Dr. P. Connett
|
| Vol #:
|
| 27
|
| |
|
|
| C 589
|
| C. Gerardi, EdM
|
| Vol #:
|
| 27
|
| |
|
|
| C 590
|
| G. Maguire
|
| Vol #:
|
| 27
|
| |
|
|
| C 591
|
| J. Palombo
|
| Vol #:
|
| 27
|
| |
|
|
| C 592
|
| Dr. B. Lafferty
|
| Vol #:
|
| 27
|
| |
|
|
| C 593
|
| J. Kelleher, PhD
|
| Vol #:
|
| 27
|
| |
|
|
| C 594
|
| Dr. K. Anderson, DDS, MS
|
| Vol #:
|
| 27
|
| |
|
|
| C 595
|
| M. Webster
|
| Vol #:
|
| 27
|
| |
|
|
| C 596
|
| O. Duke
|
| Vol #:
|
| 27
|
| |
|
|
| C 597
|
| J. Klein
|
| Vol #:
|
| 27
|
| |
|
|
| C 598
|
| J. Johnson
|
| Vol #:
|
| 27
|
| |
|
|
| C 599
|
| R. Kennedy, MD
|
| Vol #:
|
| 27
|
| |
|
|
| C 600
|
| J. Means
|
| Vol #:
|
| 27
|
| |
|
|
| C 601
|
| J. Gleiter
|
| Vol #:
|
| 27
|
| |
|
|
| C 602
|
| Aesthetic Dentistry of Bellevue
|
| Vol #:
|
| 27
|
| |
|
|
| C 603
|
| K. Jones, PhD
|
| Vol #:
|
| 27
|
| |
|
|
| C 604
|
| K. Trammel
|
| Vol #:
|
| 27
|
| |
|
|
| C 605
|
| D. Pence, DDS
|
| Vol #:
|
| 27
|
| |
|
|
| C 606
|
| Santa Monicans for Safe Drinking Water Coalition
|
| Vol #:
|
| 27
|
| |
|
|
| C 607
|
| P. Wheeldon
|
| Vol #:
|
| 27
|
|
| | | | | | | | |
| |
|
|
| C 608
|
| J. Zwaal
|
| Vol #:
|
| 27
|
| |
|
|
| C 609
|
| D. Burstrom
|
| Vol #:
|
| 27
|
| |
|
|
| C 610
|
| H. Berlin, DDS
|
| Vol #:
|
| 27
|
| |
|
|
| C 611
|
| B. Weatherbee
|
| Vol #:
|
| 27
|
| |
|
|
| C 612
|
| S. Williams
|
| Vol #:
|
| 27
|
| |
|
|
| C 613
|
| C. Gochenour
|
| Vol #:
|
| 27
|
| |
|
|
| C 614
|
| S. Holmstrom
|
| Vol #:
|
| 27
|
| |
|
|
| C 615
|
| D. Temple
|
| Vol #:
|
| 27
|
| |
|
|
| C 616
|
| L. Quayle
|
| Vol #:
|
| 27
|
| |
|
|
| C 617
|
| B. Hiley
|
| Vol #:
|
| 27
|
| |
|
|
| C 618
|
| C. McMillan
|
| Vol #:
|
| 27
|
| |
|
|
| C 619
|
| Consumers for Dental Choice
|
| Vol #:
|
| 27
|
| |
|
|
| C 620
|
| J. Frazel
|
| Vol #:
|
| 27
|
| |
|
|
| C 621
|
| K. Scott, MS
|
| Vol #:
|
| 27
|
| |
|
|
| C 622
|
| R. Schmidt, D.O.
|
| Vol #:
|
| 27
|
| |
|
|
| C 623
|
| L. Williamson
|
| Vol #:
|
| 27
|
| |
|
|
| C 624
|
| No signature
|
| Vol #:
|
| 27
|
| |
|
|
| C 625
|
| D. Manning
|
| Vol #:
|
| 27
|
| |
|
|
| C 626
|
| R. Milligan
|
| Vol #:
|
| 27
|
| |
|
|
| C 627
|
| J. HAusmann
|
| Vol #:
|
| 27
|
| |
|
|
| C 628
|
| M. Wyhe
|
| Vol #:
|
| 27
|
| |
|
|
| EMC 1148
|
| B. Segali
|
| Vol #:
|
| 24
|
| |
|
|
| EMC 1149
|
| M. Cox
|
| Vol #:
|
| 24
|
| |
|
|
| 2006N-0414
|
| Suicidality Data from Adult Antidepressant Trials
|
| |
|
|
| EC 13
|
| Mr. Frazer Merritt
|
| Vol #:
|
| 1
|
| |
|
|
| EC 14
|
| Mrs. Rosie Meysenburg
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0452
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Agreement for Shipment of Devices for Sterilization
|
| |
|
|
| EC 1
|
| Mr. Paul Meixner
|
| Vol #:
|
| 1
|
| |
|
|
| EC 2
|
| Mrs. Norene Fields
|
| Vol #:
|
| 1
|
| |
|
|
| EC 3
|
| Mr. Walter Copp
|
| Vol #:
|
| 1
|
| |
|
|
| EC 4
|
| Mr. michael nichols
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0465
|
| Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products; Public Meeting
|
| |
|
|
| NM 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0468
|
| Training Program for Regulatory Project Managers; Information Available to Industry
|
|
| | | | | | | | |
| |
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
| |
|
|
| C 22
|
| J. Shannon
|
| Vol #:
|
| 6
|
| |
|
|
| EC 430
|
| Miss. Barbara Pfouts
|
| Vol #:
|
| 7
|
| |
|
|
| 2006P-0481
|
| ANDA Suitability for Oxycodone Hydrochloride Capsules, 5 mg
|
| |
|
|
| ACK 1
|
| FDA/DDM to Actavis Totowa, LLC
|
| Vol #:
|
| 1
|
| |
|
|
| CP 1
|
| Actavis Totowa, LLC
|
| Vol #:
|
| 1
|
| |
|
|
| 2006P-0484
|
| Change the indication for Stimulant Medications for the Treatment of Mental Diseases
|
| |
|
|
| ACK 1
|
| FDA/DDM to M. McDole
|
| Vol #:
|
| 1
|
| |
|
|
| CP 1
|
| M. McDole
|
| Vol #:
|
| 1
|
| |
|
|
| 2006V-0482
|
| Laser Light Show
|
| |
|
|
| ACK 1
|
| FDA / DDM to Griffin Behm
|
| Vol #:
|
| 1
|
| |
|
|
| VAR 1
|
| Griffin Behm
|
| Vol #:
|
| 1
|
|
|
